Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 2 , Pages 291-310 , April 2010

Gonadal tumours and DSD

  • Leendert H.J. Looijenga, PhD

      Affiliations

    • Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Building Be, Room 430b, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. Tel.: +31 10 70 44329; Fax: +31 10 70 44365.
    • ,
  • Remko Hersmus, BSc, PhD student

      Affiliations

    • Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Bertie H.C.G.M. de Leeuw, PhD

      Affiliations

    • Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Hans Stoop, BSc, PhD student

      Affiliations

    • Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Martine Cools, MD, PhD

      Affiliations

    • Department of Pediatric Endocrinology, University Hospital Ghent, Belgium
    • ,
  • J. Wolter Oosterhuis, MD, PhD

      Affiliations

    • Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Stenvert L.S. Drop, MD, PhD

      Affiliations

    • Department of Pediatric Endocrinology, Erasmus MC-University Medical Center Rotterdam, Sophia, Rotterdam, The Netherlands
    • ,
  • Katja P. Wolffenbuttel, MD

      Affiliations

    • Department of Pediatric Urology, Erasmus MC-University Medical Center Rotterdam, Sophia, Rotterdam, The Netherlands

References 

  1. Oosterhuis J, Looijenga L. Testicular germ-cell tumours in a broader perspective. Nature Reviews. Cancer. 2005 Mar;5(3):210–222
  2. McLaren A. Primordial germ cells in the mouse. Developmental Biology. 2003 Oct 1;262(1):1–15
  3. Donovan PJ. The germ cell–the mother of all stem cells. The International Journal of Developmental Biology. 1998;42(7):1043–1050
  4. van de Geijn GJ, Hersmus R, Looijenga LH. Recent developments in testicular germ cell tumor research. Birth Defects Research. Part C, Embryo Today: Reviews. 2009 Mar;87(1):96–113
  5. Donovan PJ. Growth factor regulation of mouse primordial germ cell development. Current Topics in Developmental Biology. 1994;29:189–225
  6. Godin I, Deed R, Cooke J, et al. Effects of the steel gene product on mouse primordial germ cells in culture. Nature. 1991;352:807–809
  7. Wylie CC. The biology of primordial germ cells. European Urology. 1993;23:62–67
  8. Runyan C, Schaible K, Molyneaux K, et al. Steel factor controls midline cell death of primordial germ cells and is essential for their normal proliferation and migration. Development (Cambridge, England). 2006 Dec;133(24):4861–4869
  9. Hara K, Kanai-Azuma M, Uemura M, et al. Evidence for crucial role of hindgut expansion in directing proper migration of primordial germ cells in mouse early embryogenesis. Developmental Biology. 2009 Jun 15;330(2):427–439
  10. Szabo PE, Mann JR. Biallelic expression of imprinted genes in the mouse germ line: implications for erasure, establishment, and mechanisms of genomic imprinting. Genes & Development. 1995;9:1857–1868
  11. Surani MA. Reprogramming of genome function through epigenetic inheritance. Nature. 2001 Nov 1;414(6859):122–128
  12. Wilhelm D, Palmer S, Koopman P. Sex determination and gonadal development in mammals. Physiological Reviews. 2007 Jan;87(1):1–28
  13. Polanco JC, Koopman P. Sry and the hesitant beginnings of male development. Developmental Biology. 2007 Feb 1;302(1):13–24
  14. Wilhelm D, Koopman P. The makings of maleness: towards an integrated view of male sexual development. Nature Reviews. Genetics. 2006 Aug;7(8):620–631
  15. Ottolenghi C, Uda M, Crisponi L, et al. Determination and stability of sex. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology. 2007 Jan;29(1):15–25
  16. Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, et al. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 1998;106(1):198–204discussion -6
  17. Jørgensen N, Rajpert-De Meyts E, Graem N, et al. Expression of immunohistochemical markers for testicular carcinoma in situ by normal fetal germ cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. 1995;72:223–231
  18. Honecker F, Stoop H, De Krijger R, et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by foetal germ cells. The Journal of Pathology. 2004;203:849–857
  19. Gaskell TL, Esnal A, Robinson LL, et al. Immunohistochemical profiling of germ cells within the human fetal testis: identification of three subpopulations. Biology of Reproduction. 2004 Dec;71(6):2012–2021
  20. Gashaw I, Dushaj O, Behr R, et al. Novel germ cell markers characterize testicular seminoma and fetal testis. Molecular Human Reproduction. 2007 Oct;13(10):721–727
  21. Kerr CL, Hill CM, Blumenthal PD, et al. Expression of pluripotent stem cell markers in the human fetal testis. Stem Cells. 2008 Feb;26(2):412–421
  22. Stoop H, Honecker F, van de Geijn G, et al. Stem cell factor as a novel diagnostic marker for early malignant germ cells. The Journal of Pathology. 2008;216:43–54
  23. Scully RE. Germ cell tumors. In:  Scully RE editors. Tumors of the ovary and maldeveloped gonads. 1st ed.. Washington, DC: Armed Forces of Pathology; 1978;p. 226–286
  24. Mostofi FK, Sesterhenn IA. Pathology of germ cell tumors of testes. Progress in Clinical and Biological Research. 1985;203:1–34
  25. Mostofi FK, Sesterhenn IA, Davis CJJ. Immunopathology of germ cell tumors of the testis. Seminars in Diagnostic Pathology. 1987;4:320–341
  26. Donohue JP. The pathology of germ cell tumors of the testis. In:  Libertino JA editors. Testis tumors (International Perspectives in Urology). 7th ed.. Baltimore\London: Williams&Wilkins; 1990;p. 23–54
  27. Looijenga LH, Oosterhuis JW. Pathogenesis of testicular germ cell tumours. Reviews of Reproduction. 1999 May;4(2):90–100
  28. Looijenga LH, de Munnik H, Oosterhuis JW. A molecular model for the development of germ cell cancer. International Journal of Cancer. 1999 Dec 10;83(6):809–814
  29. Oosterhuis JW, Looijenga LH. Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2003 Jan;111(1):280–289
  30. Pugh RCB. Combined tumours. In:  Pugh RCB editors. Pathology of the testis. Oxford: Blackwell; 1976;p. 245–258
  31. Woodward PJ, Heidenreich A, Looijenga LHJ, et al. Testicular germ cell tumors. In:  Eble JN,  Sauter G,  Epstein JI,  Sesterhann IA editor. World Health Organization classification of tumours pathology and genetics of the urinary system and male genital organs. Lyon: IARC Press; 2004;p. 217–278
  32. Hong Y, Stambrook PJ. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14443–14448
  33. Masters JR, Koberle B. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nature Reviews. Cancer. 2003 Jul;3(7):517–525
  34. Skakkebæk NE. Possible carcinoma-in-situ of the testis. Lancet. 1972;516–517
  35. Loy V, Dieckmann KP. Carcinoma in situ of the testis: intratubular germ cell neoplasia or testicular intraepithelial neoplasia?. Human Pathology. 1990;21:457–458
  36. Looijenga LH, Stoop H, Hersmus R, et al. Genomic and expression profiling of human spermatocytic seminomas: pathogenetic implications. International Journal of Andrology. 2007 Aug;30(4):328–335discussion 35–6
  37. Oosterhuis JW, Stoop H, Honecker F, et al. Why human extragonadal germ cell tumors occur in the midline of the body; old concepts, new perspectives. International Journal of Andrology. 2007;30:256–263
  38. Scully RE. Gonadoblastoma/A review of 74 cases. Cancer. 1970;25:1340–1356
  39. Jørgensen N, Muller J, Jaubert F, et al. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology. 1997;30(2):177–186
  40. Kersemaekers AM, Honecker F, Cools M, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastomas: an immunohistochemical study for OCT3/4 and TSPY. Human Pathology. 2005;36:512–521
  41. Cools M, Stoop H, Kersemaekers AM, et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. The Journal of Clinical Endocrinology and Metabolism. 2006 Jun;91(6):2404–2413
  42. Cools M, Drop SL, Wolffenbuttel KP, et al. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocrine Reviews. 2006 May 30;27:468–484
  43. Looijenga LH, Hersmus R, Oosterhuis JW, et al. Tumor risk in disorders of sex development (DSD). Best Practice & Research. Clinical Endocrinology & Metabolism. 2007 Sep;21(3):480–495
  44. Hersmus R, de Leeuw BHCGM, Wolffenbuttel KP, et al. New insights into type II Germ Cell Tumor pathogenesis based on the studies of patients with various forms of disorders of sex development (DSD). Molecular and Cellular Endocrinology. 2008;291:1–10
  45. Van Gurp RJ, Oosterhuis JW, Kalscheuer V, et al. Human testicular germ cell tumors show biallelic expression of the H19 and IGF2 gene. Journal of the National Cancer Institute. 1994;86:1070–1075
  46. Rachmilewitz J, Elkin M, Looijenga LHJ, et al. Characterization of the imprinted IPW gene: allelic expression in normal and tumorigenic human tissues. Oncogene. 1996;13:1687–1692
  47. Verkerk AJ, Ariel I, Dekker MC, et al. Unique expression patterns of H19 in human testicular cancers of different etiology. Oncogene. 1997;14(1):95–107
  48. Looijenga LH, Verkerk AJ, Dekker MC, et al. Genomic imprinting in testicular germ cell tumours. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 1998;106(1):187–195discussion 96–7
  49. Sievers S, Alemazkour K, Zahn D, et al. IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes, Chromosomes & Cancer. 2005;44(3):256–264
  50. Kawakami T, Zhang C, Okada Y, et al. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin. Oncogene. 2006 Jun 1;25(23):3225–3236
  51. Almstrup K, Hoei-Hansen CE, Nielsen JE, et al. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. British Journal of Cancer. 2005 May 23;92(10):1934–1941
  52. M⌀ller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. European Urology. 1993;23:8–15
  53. Moller H, Skakkebæk NE. Risk of testicular cancer and cryptorchidism in relation to socio-economical status and related factors: case-control studies in Denmark. International Journal of Cancer. 1996;66:287–293
  54. Krausz C, Looijenga LHJ. Genetic aspects of testicular germ cell tumors. Cell Cycle. 2008;7:3519–3524
  55. Chaganti RS, Bosl GJ. Germ cell tumors: unraveling a biological paradox. Laboratory Investigation; a Journal of Technical Methods and Pathology. 1995;73:593–595
  56. Moller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. European Urology. 1993;23(1):8–13discussion 4–5
  57. Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection?. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 1998 Jan;106(1):3–11discussion 2
  58. Jacobsen R, Bostofte E, Engholm G, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ (Clinical Research Ed.). 2000;321(7264):789–792
  59. McGlynn KA, Devesa SS, Sigurdson AJ, et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003 Jan 1;97(1):63–70
  60. Pamenter B, De Bono JS, Brown IL, et al. Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre. BJU International. 2003 Jul;92(1):43–46
  61. Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. The Journal of Urology. 2005 Nov;174(5):1819–1822discussion 22
  62. Sonke GS, Chang S, Strom SS, et al. Prenatal and perinatal risk factors and testicular cancer: a hospital-based case-control study. Oncology Research. 2007;16(8):383–387
  63. Cook MB, Graubard BI, Rubertone MV, et al. Perinatal factors and the risk of testicular germ cell tumors. International Journal of Cancer. 2008 Mar 6;122:2600–2606
  64. Walsh TJ, Dall'era MA, Croughan MS, et al. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. The Journal of Urology. 2007 Oct;178(4):1440–1446
  65. Pettersson A, Richiardi L, Nordenskjold A, et al. Age at surgery for undescended testis and risk of testicular cancer. The New England Journal of Medicine. 2007 May 3;356(18):1835–1841
  66. Rapley EA, Crockford GP, Teare D, et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nature Genetics. 2000;24(2):197–200
  67. Holzik MF, Rapley EA, Hoekstra HJ, et al. Genetic predisposition to testicular germ-cell tumours. The Lancet Oncology. 2004 Jun;5(6):363–371
  68. Rapley EA, Turnbull C, Al Olama AA, et al. A genome-wide association study of testicular germ cell tumor. Nature Genetics. 2009 May 31;
  69. Kanetsky PA, Mitra N, Vardhanabhuti S, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nature Genetics. 2009 May 31;
  70. Hemminki K, Li X, Czene K. Cancer risks in first-generation immigrants to Sweden. International Journal of Cancer. 2002 May 10;99(2):218–228
  71. Michos A, Xue F, Michels KB. Birth weight and the risk of testicular cancer: a meta-analysis. International Journal of Cancer. 2007 Sep 1;121(5):1123–1131
  72. Cools M, Honecker F, Stoop H, et al. Maturation delay of germ cells in trisomy 21 fetuses results in increase risk for the development of testicular germ cell tumors. Human Pathology. 2006;37:101–111
  73. Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction (Oxford, England). 2001;16(5):972–978
  74. Fisher JS, Macpherson S, Marchetti N, et al. Human ‘testicular dysgenesis syndrome’: a possible model using in-utero exposure of the rat to dibutyl phthalate. Human Reproduction (Oxford, England). 2003 Jul;18(7):1383–1394
  75. Skakkebaek NE. Testicular dysgenesis syndrome. Hormone Research. 2003;60(Suppl. 3):49
  76. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Human Reproduction Update. 2006 May–Jun;12(3):303–323
  77. Sonne SB, Kristensen DM, Novotny GW, et al. Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. International Journal of Andrology. 2008 Jan 16;31:275–287
  78. Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006 Apr 19;
  79. Hughes IA. Disorders of sex development: a new definition and classification. Best Practice & Research. Clinical Endocrinology & Metabolism. 2008 Feb;22(1):119–134
  80. Isurugi K, Imao S, Hirose K, et al. Seminoma in Klinefelter's syndrome with 47, XXY, 15s+ karyotype. Cancer. 1977;39(5):2041–2047
  81. Lee MW, Stephens RL. Klinefelter's syndrome and extragonadal germ cell tumors. Cancer. 1987;60(5):1053–1055
  82. Nichols CR, Heerema NA, Palmer C, et al. Klinefelter's syndrome associated with mediastinal germ cell neoplasms. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1987;5(8):1290–1294
  83. Hasle H, Jacobsen BB, Asschenfeldt P, et al. Mediastinal germ cell tumour associated with Klinefelter syndrome. A report of case and review of the literature. European Journal of Pediatrics. 1992;151:735–739
  84. Hasle H, Mellemgaard A, Nielsen J, et al. Cancer incidence in men with Klinefelter syndrome. British Journal of Cancer. 1995;71:416–420
  85. Volkl TM, Langer T, Aigner T, et al. Klinefelter syndrome and mediastinal germ cell tumors. American Journal of Medical Genetics. Part A. 2006 Mar 1;140(5):471–481
  86. Aksglaede L, Wikstrom AM, Rajpert-De Meyts E, et al. Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Human Reproduction Update. 2006 Jan–Feb;12(1):39–48
  87. Modi DN, Sane S, Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Molecular Human Reproduction. 2003 Apr;9(4):219–225
  88. Cools M, van Aerde K, Kersemaekers AM, et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. The Journal of Clinical Endocrinology and Metabolism. 2005 Sep;90(9):5295–5303
  89. Cools M, Looijenga LH, Wolffenbuttel KP, et al. Disorders of sex development: update on the genetic background, terminology and risk for the development of germ cell tumors. World Journal of Pediatrics: WJP. 2009;5(2):93–102
  90. Batata MA, Whitmore WF, Chu FCH, et al. Cryptorchidism and testicular cancer. The Journal of Urology. 1980;124:382–387
  91. Muller J, Skakkebaek NE, Nielsen OH, et al. Cryptorchidism and testis cancer. Cancer. 1984;54:629–634
  92. Giwercman A, Grindsted J, Hansen B, et al. Testicular cancer risk in boys with maldescended testis: a cohort study. The Journal of Urology. 1987;138(5):1214–1216
  93. Abratt RP, Reddi VB, Sarembock LA. Testicular cancer and cryptorchidism. British Journal of Urology. 1992;70:656–659
  94. Ogunbiyi JO, Shittu OB, Aghadiuno PU, et al. Seminoma arising in cryptorchid testes in Nigerian males. East African Medical Journal. 1996;73(2):129–132
  95. Susnerwala SS, Pande SC, Shrivastava SK, et al. Dysgerminoma of the ovary: review of 27 cases. Journal of Surgical Oncology. 1991 Jan;46(1):43–47
  96. Dietl J, Horny HP, Ruck P, et al. Dysgerminoma of the ovary. An immunohistochemical study of tumor- infiltrating lymphoreticular cells and tumor cells. Cancer. 1993;71(8):2562–2568
  97. Chow SN, Yang JH, Lin YH, et al. Malignant ovarian germ cell tumors. International Journal of Gynecologyand Obstetrics. 1996;53:151–158
  98. Cusido MT, Jorda B, Gonzalez J, et al. Ovarian germ cell tumors. European Journal of Gynaecological Oncology. 1998;19(2):130–134
  99. Tewari K, Cappuccini F, Disaia PJ, et al. Malignant germ cell tumors of the ovary. Obstetrics and Gynecology. 2000 Jan;95(1):128–133
  100. Li Y, Vilain E, Conte F. Rajpert-De Meyts E, Lau YF. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Urologic Oncology. 2007 Mar-Apr;25(2):141–146
  101. Hersmus R, Kalfa N, De Leeuw B, et al. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). The Journal of Pathology. 2008;215:31–38
  102. Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development (Cambridge, England). 1987;101(Suppl):151–155
  103. Bianco B, Lipay M, Guedes A, et al. SRY gene increases the risk of developing gonadoblastoma and/or nontumoral gonadal lesions in Turner syndrome. International Journal of Gynecological Pathology. 2009 Jan 30;
  104. Hersmus R, de Leeuw BH, Stoop H, et al. A novel SRY missense mutation affecting nuclear import in a 46, XY female patient with bilateral gonadoblastoma. European Journal of Human Genetics : EJHG. 2009 Jun 10;
  105. Ng SB, Yong MH, Knight LA, et al. Gonadoblastoma-associated mixed germ cell tumour in 46, XY complete gonadal dysgenesis (Swyer syndrome): analysis of Y chromosomal genotype and OCT3/4 and TSPY expression profile. Histopathology. 2008 Apr;52(5):644–646
  106. Beaulieu Bergeron M, Bouron-Dal Soglio D, Maietta A, et al. Co-existence of a choriocarcinoma and a gonadoblastoma in the gonad of a 46, XY female: A SNP array analysis. Pediatric and Developmental Pathology. 2009 May 8;1
  107. Kini U, Bantwal G, Ayyar V, et al. Bilateral gonadoblastomas with a left sided dysgerminoma in a true hermaphrodite (disorder of sexual differentiation) with 46, XY karyotype. The Journal of the Association of Physicians of India. 2008 Jul;56:549–551
  108. Simon RA, Laughlin TS, Nuccie B, et al. 46 XY phenotypic female adolescent with bilateral gonadal tumors consisting of five different components. International Journal of Gynecological Pathology. 2008 Jul;27(3):407–411
  109. Cools M, Boter M, van Gurp R, et al. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads. Clinical Endocrinology. 2007 Aug;67(2):184–192
  110. Vogel T, Schmidtke J. Structure and function of TSPY, the Y-chromosome gene coding for the “testis-specific protein”. Cytogenetics and Cell Genetics. 1998;80(1–4):209–213
  111. Lau YF. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. American Journal of Human Genetics. 1999;64(4):921–927
  112. Li Y, Tabatabai ZL, Lee TL, et al. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Human Pathology. 2007 Oct;38(10):1470–1481
  113. Lau YF, Lau HW, Komuves LG. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenetic and Genome Research. 2003;101(3–4):250–260
  114. Schnieders F, Dork T, Arnemann J, et al. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Human Molecular Genetics. 1996;5(11):1801–1807
  115. Hildenbrand R, Schroder W, Brude E, et al. Detection of TSPY protein in a unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. The Journal of Pathology. 1999;189(4):623–626
  116. Delbridge ML, Longepied G, Depetris D, et al. TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X - implications for Y chromosome evolution. Chromosome Research. 2004;12(4):345–356
  117. Oram SW, Liu XX, Lee TL, et al. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer. 2006;6:154
  118. Looijenga LHJ, Zafarana G, Grygalewicz B, et al. Role of gain of 12p in germ cell tumour development. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2003;111:161–173
  119. Hammes A, Guo JK, Lutsch G, et al. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell. 2001;106(3):319–329
  120. Schumacher V, Gueler B, Looijenga LH, et al. Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome. Molecular Reproduction and Development. 2008 Feb 12;
  121. Andrade JG, Guaragna MS, Soardi FC, et al. Clinical and genetic findings of five patients with WT1-related disorders. Arquivos brasileiros de endocrinologia e metabologia. 2008 Nov;52(8):1236–1243
  122. Looijenga LHJ, Stoop H, De Leeuw PJC, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Research. 2003;63:2244–2250
  123. de Jong J, Stoop H, Dohle GR, et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. The Journal of Pathology. 2005 Jun;206(2):242–249
  124. De Jong J, Looijenga LHJ. Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. OCT3/4 in oncogenesis. Critical Reviews in Oncogenesis. 2006;12(3–4):171–203
  125. Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. The Journal of Pathology. 2007 Jan;211(1):1–9
  126. van Casteren NJ, Boellaard WP, Dohle GR, et al. Heterogeneous distribution of ITGCNU in an adult testis: consequences for biopsy-based diagnosis. International Journal of Surgical Pathology. 2008 Jan;16(1):21–24
  127. van Casteren NJ, Stoop H, Dohle GR, et al. noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. European Urology. 2008 Jul;54(1):153–160
  128. Lev S, Blechman JM, Givol D, et al. Steel factor and c-kit protooncogene: genetic lessons in signal transduction. Critical Reviews in Oncogenesis. 1994;5(2–3):141–168
  129. Yan W, Kero J, Huhtaniemi I, et al. Stem cell factor functions as a survival factor for mature Leydig cells and a growth factor for precursor Leydig cells after ethylene dimethane sulfonate treatment: implication of a role of the stem cell factor/c-Kit system in Leydig cell development. Developmental Biology. 2000 Nov 1;227(1):169–182
  130. Biermann K, Klingmuller D, Koch A, et al. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas. Histopathology. 2006 Sep;49(3):290–297
  131. Goddard NC, McIntyre A, Summersgill B, et al. KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature. International Journal of Andrology. 2007 Aug;30(4):337–348discussion 49
  132. McIntire KR, Summersgill B, Grygalewicz B, et al. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Research. 2005;65:8085–8089
  133. Looijenga LHJ, De Leeuw PJC, Van Oorschot M, et al. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ cell tumors. Cancer Research. 2003;63:7674–7678
  134. Biermann K, Goke F, Nettersheim D, et al. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. The Journal of Pathology. 2007 Nov;213(3):311–318
  135. Hoei-Hansen CE, Kraggerud SM, Abeler VM, et al. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Molecular Cancer. 2007;6:12
  136. Henderson BE, Bernstein L, Ross RK, et al. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. British Journal of Cancer. 1988;57(2):216–218
  137. Weir HK, Marrett LD, Kreiger N, et al. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. International Journal of Cancer. 2000;87(3):438–443
  138. Wilkinson TJ, Colls BM, Schluter PJ. Increased incidence of germ cell testicular cancer in New Zealand Maoris. British Journal of Cancer. 1992;65(5):769–771
  139. Starr JR, Chen C, Doody DR, et al. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer Epidemiology, Biomarkers & Prevention. 2005 Sep;14(9):2183–2190
  140. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives. 1996;104(Suppl. 4):741–803
  141. Rajpert-De Meyts E, Toppari J, Hoi-Hansen CE, et al. Testicular neoplasia in childhood and adolescence. Endocrine Development. 2003;5:110–123
  142. Welsh M, Saunders PT, Fisken M, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. The Journal of Clinical Investigation. 2008 Apr;118(4):1479–1490
  143. Hannema SE, Scott IS, Rajpert-De Meyts E, et al. Testicular development in the complete androgen insensitivity syndrome. The Journal of Pathology. 2006 Mar;208(4):518–527
  144. Cheikhelard A, Morel Y, Thibaud E, et al. Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. The Journal of Urology. 2008 Oct;180(4):1496–1501
  145. Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU International. 2000 Jan;85(1):120–124

PII: S1521-690X(09)00139-0

doi: 10.1016/j.beem.2009.10.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 2 , Pages 291-310 , April 2010

Article Tools

* Image Usage & Resolution